Our team of physicians and digestive care experts offer procedures, services, and facilities based on the latest medical advances that can be challenging to find elsewhere. One of the most experienced in the country, our program provides comprehensive care and a wide range of treatment options, all in one location.
Liver Transplantation Offers a Promising Option for Colorectal Cancer Liver Metastases
Weill Cornell Medicine physicians are leading cutting-edge treatments for patients with colorectal cancer liver metastases (CRLM).
Dr. Bo Shen: A Career Dedicated to Transforming Care for Complex IBD and Ileal Pouch Disorders
Medical Director of Columbia’s Inflammatory Bowel Disease Center transforms the field of interventional IBD for the management of complex IBD and pouch disorders.
Women and Black Patients at Significant Disadvantage in Receiving Liver Transplants
A Weill Cornell transplant hepatologist developed a novel metric to demonstrate disparities in liver transplantation for alcohol-associated disease.
Bridging the Gap Between Primary Care and Hepatology for Diabetes Patients at-risk for NAFLD
Weill Cornell Medicine hepatologist implements algorithm to detect nonalcoholic fatty liver disease with advanced fibrosis in primary care patients with diabetes
NewYork-Presbyterian: Focused on Detecting and Preventing High-Risk GI Cancers
The Gastrointestinal Cancer Prevention and Genetics Program at NewYork-Presbyterian/Columbia is Leading the Way to Defeat High-Risk Familial Cancers
NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease
The IBD Center at Columbia leads enrollment in an early feasibility study of sacral nerve stimulation for the treatment of Crohn’s disease and ulcerative colitis.
Celiac Disease: NewYork-Presbyterian Gastroenterologist Addresses Misinformation and Treatment Challenges
Columbia gastroenterologists discuss new guidelines for diagnosing celiac disease, provide education about non-celiac gluten sensitivity, and highlight ongoing research.
NewYork-Presbyterian Offers Innovative Approach to Treating Cancer in the Peritoneal Cavity
Weill Cornell Medicine faculty now provide cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC)
A Novel Treatment for Nonmetastatic Colon Cancer Meets Major Milestone in Phase 1 Clinical Trial
Weill Cornell Medicine faculty lead Phase 1 clinical trial demonstrating that starting adjuvant chemotherapy at the time of surgery is a safe and feasible approach to treating colon cancer.
Examining real-world use of ustekinumab in treating Crohn’s disease
Weill Cornell Medicine gastroenterologists participate in a multicenter, multinational consortium to study the safety and effectiveness of a new biologic treatment for Crohn’s disease.
The Role of Body Mass Index and other Risk Factors for Cancer in Adults with Cystic Fibrosis
Although cystic fibrosis patients are at higher risk of developing cancer, a Columbia gastroenterologist and cancer specialist discover that higher BMI was associated with reduced, not increased, risk of cancer in transplanted adults with cystic fibrosis.
Antivirals and Organ Transplant Recipients: Experts Offer Management Recommendations
Weill Cornell Medicine and Columbia specialists in organ transplantation offer guidelines in managing clinically significant drug-drug interactions with Paxlovid and transplant immunosuppressants.
Investigating Ileal Pouch-Anal Anastomosis and Pouch Dysfunction
A noted Columbia colorectal surgeon investigates the symptoms, causes, and treatments of patients to better understand the physiology of ileal pouch-anal anastomosis and poor pouch emptying.
Assessing Long-Term Cancer Risk in Alcohol-Related Liver Disease
An international research team that includes Columbia faculty in gastroenterology and hepatology evaluates the long-term risk of hepatocellular carcinoma in persons with ALD to determine if surveillance is warranted.
Advancing the Early Detection of Pancreatic Cancer
At Columbia, Dr. Anil Rustgi presents insights into the current state of genetic testing, screening and surveillance with a goal to diagnose pancreatic cancer at a more treatable stage.
Leading Consensus Efforts on Managing Inflammatory Pouch Disorders
A Columbia IBD interventionalist and a colorectal surgeon spearhead development of practice guidelines for inflammatory pouch disorders.
Crohn’s Disease: Confronting the Ongoing Challenge of Post-Operative Recurrence
Dr. Fabrizio Michelassi, Weill Cornell Medicine Chairman of Surgery, reports on how advances in bowel-sparing procedures are helping to optimize outcomes for patients.
Esophagology: An Evolving Subspecialty Whose Time Has Come
Columbia gastroenterologist and leading authority in esophageal disorders establishes the Esophagology and Swallowing Center with a special focus on the management of eosinophilic esophagitis and esophageal atresia.
Same-Day Colectomy: A New Option for Select Patients?
Columbia colorectal surgeons evaluate the feasibility and safety of ambulatory surgery “fast track” recovery protocols in carefully selected patients undergoing colorectal resection and anastomosis.
How Toxin-Producing Yeast Strains in the Gut Fuel Inflammatory Bowel Disease
Weill Cornell Medicine faculty discover that C. albicans strains may damage the gut of patients with inflammatory bowel disease, and these findings could potentially inform personalized treatment approaches.
Assessing Techniques to Prevent Anastomotic Leak
A renowned colorectal surgeon at Weill Cornell Medicine provides an in-depth discussion of techniques developed to reduce the rate of anastomotic leak following bowel surgery.
The Complex Biology Behind Gastric Cancers
Columbia gastroenterology faculty examine the role of stem cells in the development of cancer in the upper gastrointestinal tract.
Leading the Way in Living Donor Liver Transplantation
Key Growth Factor Protects Gut from Inflammatory Bowel Disease
Weill Cornell Medicine researchers discover a new cellular pathway that is essential to protect against gut inflammation that could lead to a better understanding of IBD pathogenesis and new treatment strategies.
Abdominal Wall Surgery: Redefining Expertise for an Emerging Specialty
Columbia Hernia Center surgeons present factors that are changing the surgical landscape for hernia repair from open operations to minimally invasive approaches.
Benefits of Colonic Stents as a Bridge to Surgery
Weill Cornell Medicine surgical oncologist and colon and rectal surgeon, Dr. Heather Yeo, and her team conduct the first study to use propensity score matching comparing colonic stenting with immediate resection.
Familial Pancreatic Cancer: Confronting the Risk
Columbia gastroenterologists discuss hereditary cancer syndromes associated with pancreatic cancer and approaches to identify risk.
Advancing Understanding and Management of Fatty Liver Disease
Gastroenterologists at NewYork-Presbyterian Hospital continue to characterize the biological mechanisms of non-alcoholic fatty liver disease, define best practices for its management, and pursue research to identify effective treatment options.
Lynch Syndrome: Reducing the Risk of Cancer with Genetic Precision
Comprehensive GI Clinical Cancer Genetics programs at NewYork-Presbyterian Hospital are furthering understanding of inherited cancer syndromes such as Lynch syndrome to facilitate early screening and prevent the development of colorectal cancer.
Spearheading Advances in Bariatric Surgery
Comprehensive and collaborative bariatric surgery and weight management programs at NewYork-Presbyterian Hospital are providing integrated care by endocrinologists and surgeons, helping patients achieve significant and durable weight loss and improve overall health.
Tackling Treatment Challenges in IBD
Columbia and Weill Cornell gastroenterologists and GI surgeons are advancing the care of inflammatory bowel disease, including pouch disorders, though new program initiatives and research that span a range of investigations from the laboratory to the clinic to further development of effective therapies.
Revealing the Role of Stem Cells in Gut Regeneration
Studies of intestinal stem cells are shedding light on the mechanisms of gut regeneration. A physician-scientist at NewYork-Presbyterian/
A New Pancreatitis Program: Comprehensive Care for Progressive Pancreatic Disease
Given our experience and the enormous volume of patients with pancreatic disease that we see here at Columbia, we felt that it was valuable to formalize our treatment of these patients with a full-service program.
Proton Pump Inhibitors: The Risk-Benefit Equation
Proton pump inhibitors (PPIs) have become one of the top oral medications in the United States. With the rise of use, clinicians and researchers at NewYork-Presbyterian/
Fecal Microbiota Transplant: An Old Remedy Made New
While the use of fecal material as a medical remedy dates back to the fourth century, usage waned. In recent years, fecal microbiota transplant to control multiple relapses of Clostridium difficile infections is rising.
Pancreatic Cysts: When Is There a Cause for Concern?
The Pancreatic Cyst Surveillance Program at NewYork-Presbyterian/
A Long and Winding Road: Scoping Out Uncharted Territory in the Colon
The DiLumen Endolumenal Interventional Platform (EIP) developed at NewYork-Presbyterian/
Newsletters for Medical Professionals
2023 Issue 3
- Bridging the Gap Between Primary Care and Hepatology for Diabetes Patients at-risk for NAFLD
- NewYork-Presbyterian: Focused on Detecting and Preventing High-Risk GI Cancers
2023 Issue 2
- First Patient Enrolled in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease
- Innovative Approach To Treating Cancer in the Peritoneal Cavity
2023 Issue 1
- Examining Real-World Use of Ustekinumab in Treating Crohn’s Disease
- The Role of Body Mass Index and Other Risk Factors for Cancer in Adults with Cystic Fibrosis
2022 Issue 4
2022 Issue 3
2022 Issue 2
- Establishing Practice Guidelines for Endoscopic Evaluation of Altered Bowel Anatomy
- Bacteria Underlie Success of Fecal Microbiota Transplants for Ulcerative Colitis
2022 Issue 1
2021 Issue 3
2021 Issue 2
2021 Issue 1
2020 Issue 1
- Dr. Bo Shen: Leading the Way in IBD and Pouch Disorders
- Innovative Center Addresses GI Complications of Obesity
2019 Issue 2
- Redefining Selection Policies for HCC Liver Transplantation
- A New Pancreatitis Program: Comprehensive Care for Progressive Pancreatic Disease
- Major Faculty Expansion in Gastroenterology and GI Surgery
2019 Issue 1
- Research Highlights: Targeting Challenges in Digestive Disease
2018 Issue 2
- A Long and Winding Road: Scoping Out Uncharted Territory in the Colon
- Revealing the Role of Stem Cells in Gut Regeneration
2018 Issue 1
- Pancreatic Cysts: When Is There a Cause for Concern?
- Fecal Microbiota Transplant: An Old Remedy Made New
2017 Issue 2
- Mobile Health Technology: Tracking Postop Recovery to Improve Outcomes
- Proton Pump Inhibitors: The Risk-Benefit Equation
2017 Issue 1
- Motility Disorders: A Comprehensive Management Approach
- NAFLD Research: Making Progress on Many Fronts